BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7323688)

  • 1. Characteristics of C3b-binding in chronic liver diseases.
    Hautanen A; Salaspuro MP
    Scand J Gastroenterol; 1981; 16(4):505-12. PubMed ID: 7323688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.
    Jaffe CJ; Vierling JM; Jones EA; Lawley TJ; Frank MM
    J Clin Invest; 1978 Nov; 62(5):1069-77. PubMed ID: 711852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
    Viitala K; Israel Y; Blake JE; Niemelä O
    Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear autoantibodies in chronic liver diseases.
    Konikoff F; Isenberg DA; Barrison I; Theodor E; Shoenfeld Y
    Hepatogastroenterology; 1989 Oct; 36(5):341-5. PubMed ID: 2620901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
    Gonzàlez-Quintela A; Alende MR; Gamallo R; Gonzàlez-Gil P; López-Ben S; Tomé S; Otero E; Torre JA
    Hepatogastroenterology; 2003; 50(54):2121-6. PubMed ID: 14696478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in chronic liver disease.
    Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
    Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP; Laitinen OI; Lehtola J; Makkonen H; Räsänen JA; Sipponen P
    Scand J Gastroenterol; 1976; 11(3):313-20. PubMed ID: 1273506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to ribosomes in chronic active hepatitis.
    Gerber MA; Shapiro JM; Smith H; Lebwohl O; Schaffner F
    Gastroenterology; 1979 Jan; 76(1):139-43. PubMed ID: 758135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum secretory IgA, IgA1 and IgA2 subclasses in inflammatory bowel and chronic liver diseases.
    Soppi E; Granfors K; Leino R
    J Clin Lab Immunol; 1987 May; 23(1):15-7. PubMed ID: 3612757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years.
    Gupta RC; Dickson ER; McDuffie FC; Baggenstoss AH
    Clin Exp Immunol; 1978 Oct; 34(1):19-27. PubMed ID: 750118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between helper/suppressor ratio and IgA levels in the peripheral blood from patients with liver diseases.
    Fiorini G; Monarca A; Adelasco L; Croce G; Natangelo R; Gibelli A
    Biomed Pharmacother; 1983; 37(4):180-3. PubMed ID: 6229288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3b binding immune complexes and immunoconglutinins in human sera. Detection by enzyme-linked immunosorbent assay (ELISA).
    Hautanen A; Linder E
    J Immunol Methods; 1979; 30(4):367-80. PubMed ID: 512366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of antibodies to calreticulin of the IgA class in primary biliary cirrhosis: a possible role of gut-derived bacterial antigens in its aetiology?
    Kreisel W; Siegel A; Bahler A; Spamer C; Schiltz E; Kist M; Seilnacht G; Klein R; Berg PA; Heilmann C
    Scand J Gastroenterol; 1999 Jun; 34(6):623-8. PubMed ID: 10440614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC.
    Foreman AL; Lemercier B; Lim A; Kourlisky P; Kenny T; Gershwin ME; Gougeon ML
    Autoimmunity; 2008 Feb; 41(1):80-6. PubMed ID: 18176868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil function in chronic liver disease.
    Campbell AC; Dronfield MW; Toghill PJ; Reeves WG
    Clin Exp Immunol; 1981 Jul; 45(1):81-9. PubMed ID: 7030541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired monocyte function in primary biliary cirrhosis.
    Olmos JM; García JD; Jiménez A; de Castro S
    Allergol Immunopathol (Madr); 1988; 16(5):353-8. PubMed ID: 3228054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions.
    Hosoda H; Okawa-Takatsuji M; Tanaka A; Uwatoko S; Aotsuka S; Hasimoto N; Ozaki Y; Ikeda Y
    Clin Chim Acta; 2004 Apr; 342(1-2):71-81. PubMed ID: 15026266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlations and significance of orceinpositivity in chronic active hepatitis and primary biliary cirrhosis.
    Salaspuro MP; Sipponen P; Ikkala E; Kolho L; Makkonen HM; Miettinen TA; Räsänen JA; Siurala M
    Ann Clin Res; 1976 Jun; 8(3):206-15. PubMed ID: 63265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.
    Björkland A; Lööf L; Mendel-Hartvig I; Tötterman TH
    J Immunol; 1994 Sep; 153(6):2750-7. PubMed ID: 8077679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.